The European Cancer Congress 2015

login
My congress planner
close
Forgot password

Create account

Searchable Programme for ECC2015

Keyword / Author:
  • 26
    SAT
    07:45 – 08:30
    Genitourinary Malignancies

    Teaching Lecture: The Role of Radiotherapy in Locally Advanced Prostate Cancer: Is the Target Changing?

    Chair: T. Wiegel (Germany)

    Speaker: A. Bossi (France)

  • 26
    SAT
    10:30 – 12:20
    Poster board nr
    Abstract nr
    Genitourinary Malignancies

    Proffered Paper Session: Genitourinary Malignancies – Prostate Cancer

    Chair: M. Hoyer (Denmark)

    Chair: M. Hoyer (Denmark)

    Chair: R. Cathomas (Switzerland)

    Chair: R. Cathomas (Switzerland)

    10:30
    2500
    Orteronel (Ort) maintenance therapy in patients (pts) with metastatic castration resistant prostate cancer (mCRPC) and non-progressive disease after first-line docetaxel (Doc) therapy: Results of a multicenter randomized double-blind placebo-controlled phase III trial (SAKK 08/11)
    R. Cathomas, S. Crabb, H. Kenner, M. Mark, C. Rothermundt, T. Elliott, R. Winterhalder, P. Von Burg, S. Berardi Vilei, S. Hayoz, D. Rauch, E. Roggero, F. Stenner, D. Berthold, A. Erdmann, N. Fischer, G. Manetsch, S. Gillessen
    Display abstract

    10:45
    2501
    A randomized, open-label, phase 2 study of enzalutamide as neoadjuvant therapy for patients undergoing prostatectomy for localized prostate cancer
    B. Montgomery, A. Joshua, M. Gleave, N. Fleshner, G. Bubley, L. True, M. Tretiakova, K. Wu, W. Novotny, A. Peterson, A. Amelsberg, M.E. Taplin
    Display abstract

    11:00
    2502
    TAK-385, an oral GnRH antagonist: efficacy and safety results from a randomized phase 2 trial in prostate cancer patients (pts)
    N. Shore, J. Bailen, C. Pieczonka, D. MacLean, H. Shi, H. Faessel, F. Saad
    Display abstract

    11:15
    Discussant : B. Tombal (Belgium)

    11:25
    2503
    Hypermethylation of a specific area in the TERT promoter defines a novel risk stratification biomarker for prostate cancer patients submitted to radical prostatectomy
    P. Castelo-Branco, R. Leão, R.A. De Mello, T. Lipman, B. Campbell, A. Price, C. Zhang, S. Buerno, A. Gomes, R.G. Bristow, M. Schweiger, R. Hamilton, A. Zlotta, A. Figueiredo, H. Klocker, H. Sueltmann, U. Tabori
    Display abstract

    11:40
    2504
    Genomic predictive and prognostic factors from plasma cell-free DNA (cfDNA) for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) commencing enzalutamide (ENZ)
    K. Chi, A. Azad, S. Volik, A. Haegert, S. Le Bihan, B. McConeghy, M. Gleave, A. Wyatt, C. Collins
    Display abstract

    11:55
    2505
    TMPRSS2-ERG in blood and docetaxel response in metastatic castration-resistant prostate cancer
    O. Reig, M. Marín-Aguilera, G. Carrera, N. Jiménez, S. García-Recio, L. Gaba, M.V. Pereira, P. Fernandez, A. Prat, B. Mellado
    Display abstract

    12:10
    Discussant : H. Scher (USA)

  • 26
    SAT
    15:15 – 16:15
    Genitourinary Malignancies

    Special Session: Minimally Elevated PSA after Prostatectomy: Hold Your Horses or All Hands on Deck?

    Chair: W.J. Oyen (United Kingdom)

    15:15
    Role of advanced MRI for detection of minimal disease
    Speaker: H.C. Thoeny (Switzerland)
    Display Presentation Details

    15:25
    Role of PSMA-PET/CT for detection of minimal disease
    Speaker: B.J. Krause (Austria)
    Display Presentation Details

    15:35
    All hands on deck: Early image-guided high-precision treatment
    Speaker: V. Khoo (United Kingdom)
    Display Presentation Details

    15:45
    Hold your horses: Wait and see, do not overtreat
    Speaker: C. Bangma (Netherlands)

    15:55
    Discussion

  • 26
    SAT
    16:45 – 18:15
    Genitourinary Malignancies

    Scientific Symposium: Predictive Factors in Different Areas of Prostate Cancer

    Chair: R. Cathomas (Switzerland)
    Display Presentation Details

    Co-Chair: B. Tombal (Belgium)

    16:45
    How to distinguish between significant and insignificant localised prostate cancer
    Speaker: A. Bjartell (Sweden)
    Display Presentation Details

    17:05
    Predictive factors in radiotherapy induced toxicity
    Speaker: D. Dearnaley (United Kingdom)
    Display Presentation Details

    17:25
    Detection of predictive biomarkers in prostate cancer with novel molecular tools
    Speaker: T. Van Der Kwast (Canada)
    Display Presentation Details

    17:45
    Predictive factors for treatment choice in metastatic castration resistant prostate cancer
    Speaker: H. Scher (USA)

    18:05
    Discussion & Roundup

  • 27
    SUN
    08:00 – 08:45
    Genitourinary Malignancies

    Teaching Lecture: New Targets in Renal Cell Carcinoma: What Can We Expect for the Future?

    Chair: C.N. Sternberg (Italy)

    Speaker: B. Escudier (France)

Print / Download as PDF